The FDA granted 510(k) clearance to Axilum Robotics’ TMS-Cobot, a device that helps position and orient the MagVenture TMS therapy system.
The TMS-Cobot includes a proprietary optical tracking system that enables the user to control, in real-time, the MagVenture’s position, orientation and contact. The device can also compensate for patient head movement.
The MagVenture, which delivers transcranial magnetic stimulation, has been cleared by the FDA for the treatment of major depressive disorder in patients who have not seen satisfactory improvement from antidepressant drugs.
